LBA48_PRCTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non-small cell lung cancer (EMERGING): A randomised study. (23rd October 2018) - Zhong, W-Z; Wu, Y-L; Chen, K-N; Chen, C; Gu, C-D; Wang, Q; Wang, J; Mao, W; Qiao, G-B; Cheng, Y; Xu, L; Wang, C-L; et al.